Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Johnson and Johnson
AstraZeneca
Mallinckrodt
Colorcon

Last Updated: November 27, 2022

CLINICAL TRIALS PROFILE FOR AMLODIPINE AND OLMESARTAN MEDOXOMIL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Amlodipine And Olmesartan Medoxomil

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00185133 ↗ Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension Completed Daiichi Sankyo Inc. Phase 3 2005-05-01 This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age
NCT00185133 ↗ Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension Completed Daiichi Sankyo, Inc. Phase 3 2005-05-01 This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age
NCT00220220 ↗ Amlodipine as add-on to Olmesartan in Hypertension Completed Sankyo Pharma Gmbh Phase 3 2005-04-01 Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with olmesartan alone.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Amlodipine And Olmesartan Medoxomil

Condition Name

Condition Name for Amlodipine And Olmesartan Medoxomil
Intervention Trials
Essential Hypertension 6
Hypertension 6
Healthy Subjects 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Amlodipine And Olmesartan Medoxomil
Intervention Trials
Hypertension 12
Essential Hypertension 6
Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Amlodipine And Olmesartan Medoxomil

Trials by Country

Trials by Country for Amlodipine And Olmesartan Medoxomil
Location Trials
United States 122
Germany 5
Philippines 3
Belgium 2
Netherlands 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Amlodipine And Olmesartan Medoxomil
Location Trials
Florida 4
Ohio 4
Virginia 4
Nevada 4
North Carolina 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Amlodipine And Olmesartan Medoxomil

Clinical Trial Phase

Clinical Trial Phase for Amlodipine And Olmesartan Medoxomil
Clinical Trial Phase Trials
Phase 4 4
Phase 3 7
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Amlodipine And Olmesartan Medoxomil
Clinical Trial Phase Trials
Completed 13
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Amlodipine And Olmesartan Medoxomil

Sponsor Name

Sponsor Name for Amlodipine And Olmesartan Medoxomil
Sponsor Trials
Daiichi Sankyo Inc. 6
Daiichi Sankyo, Inc. 6
Sankyo Pharma Gmbh 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Amlodipine And Olmesartan Medoxomil
Sponsor Trials
Industry 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Dow
Medtronic
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.